Studies have demonstrated that AMPK activation can increase the absorption and utilization of FAO and glucose by B cells, enhance the proliferation and migration ability of B cells in vivo, and thus inhibit tumor growth, which has been widely a concern in tumor immunotherapy [98]. Here, PRKAA1 is linked to neoplasm.